NCT00966511

Brief Summary

The primary purpose of the study is to investigate the use of VRI to guide the selection of patients for lung surgery. Perfusion scintigraphy is the current method to assess the fractional contribution of lung function of the remaining lung. The hypothesis is that VRI can determine quantitative postoperative lung function equally accurately as a quantitative perfusion scan.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2009

Typical duration for all trials

Geographic Reach
1 country

6 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 27, 2009

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
Last Updated

February 9, 2011

Status Verified

February 1, 2011

Enrollment Period

2.3 years

First QC Date

August 26, 2009

Last Update Submit

February 8, 2011

Conditions

Keywords

lung cancerlung resectionlobectomypneumonectomylung functionperfusion

Outcome Measures

Primary Outcomes (1)

  • Comparison of ppo FEV1 and ppo DLCO as predicted by VRI with the values as predicted by Q scan

    Prior to surgery

Secondary Outcomes (1)

  • Comparison of ppo as predicted by each test with the actual FEV1 and DLCO at 3 months post-operative

    3 months after surgery

Study Arms (1)

Lung resection candidates

Study participants will be patients who are candidates for lung resection (lobectomy or greater)

Procedure: Lung resection surgery

Interventions

The study is designed in a way that will not alter the surgeon's decision based on routine assessment of candidates for resection (lobectomy or greater). Namely, the VRI data will be gathered prospectively; however, the analyses using VRI data will be performed retrospectively.

Lung resection candidates

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Study participants will be patients who are candidates for lung resection (lobectomy or greater)

You may qualify if:

  • Able and willing to read, understand, and provide written Informed Consent;
  • Age range of 18-90 years;
  • Potential candidate for at least lobectomy due to lung cancer or other intrathoracic malignancy (either suspected or proven by biopsy). Both open and minimally invasive (thoracoscopic) resections are acceptable.
  • BMI \> 19.

You may not qualify if:

  • Body habitus or skin condition that might prevent the placement of the sound sensors on the back (e.g. severe scoliosis, kyphosis, chest wall deformation, skin lesion on the back or compression fracture);
  • There should be no active pulmonary infection (e.g. pneumonia) at the time of the recordings;
  • Hirsutism unless patient is willing to have back shaved;
  • Potentially contagious skin lesion on the back;
  • Giant bulla (more than 1/3 of the hemithorax or \>10cm)
  • Pregnant women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Yale University School of Medicine

New Haven, Connecticut, 06520-8062, United States

Location

Emory University

Atlanta, Georgia, 30322, United States

Location

Boston Medical Center, Boston University

Boston, Massachusetts, 02118, United States

Location

Mt. Sinai School of Medicine

New York, New York, 10029, United States

Location

New York-Presbyterian Hospital/Columbia University Medical Center

New York, New York, 10032, United States

Location

The University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Publications (6)

  • Dellinger RP, Parrillo JE, Kushnir A, Rossi M, Kushnir I. Dynamic visualization of lung sounds with a vibration response device: a case series. Respiration. 2008;75(1):60-72. doi: 10.1159/000103558. Epub 2007 Jun 4.

    PMID: 17551264BACKGROUND
  • Kramer MR, Raviv Y, Hardoff R, Shteinmatz A, Amital A, Shitrit D. Regional breath sound distribution analysis in single-lung transplant recipients. J Heart Lung Transplant. 2007 Nov;26(11):1149-54. doi: 10.1016/j.healun.2007.07.039.

    PMID: 18022081BACKGROUND
  • Yigla M, Gat M, Meyer JJ, Friedman PJ, Maher TM, Madison JM. Vibration response imaging technology in healthy subjects. AJR Am J Roentgenol. 2008 Sep;191(3):845-52. doi: 10.2214/AJR.07.3151.

    PMID: 18716118BACKGROUND
  • Guntupalli KK, Reddy RM, Loutfi RH, Alapat PM, Bandi VD, Hanania NA. Evaluation of obstructive lung disease with vibration response imaging. J Asthma. 2008 Dec;45(10):923-30. doi: 10.1080/02770900802395496.

    PMID: 19085584BACKGROUND
  • Becker HD, Slawik M, Miyazawa T, Gat M. Vibration response imaging as a new tool for interventional-bronchoscopy outcome assessment: a prospective pilot study. Respiration. 2009;77(2):179-94. doi: 10.1159/000182972. Epub 2008 Dec 9.

    PMID: 19065052BACKGROUND
  • Colice GL, Shafazand S, Griffin JP, Keenan R, Bolliger CT; American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep;132(3 Suppl):161S-77S. doi: 10.1378/chest.07-1359.

    PMID: 17873167BACKGROUND

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Frank C Detterbeck, MD

    Yale University Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

August 26, 2009

First Posted

August 27, 2009

Study Start

June 1, 2009

Primary Completion

October 1, 2011

Study Completion

December 1, 2011

Last Updated

February 9, 2011

Record last verified: 2011-02

Locations